Anxiety And Depression During COVID-19 IN INDIA

NCT04369300 | Unknown

• 1 other identifier: Covid-19/MHC/PSYCH/20-10
• Study Type: observational
• Target: 1,000
• Locations: 1 country
• Sites: 1

Brief Summary

1. 1.To understand the prevalence of symptoms of Depression and Anxiety in general population during COVID-19 in India
2. 2.To understand correlation between COVID-19 related factors and mental health symptomology in the general population in India
3. 3.Demographic Information Demographic variables included Gender, Age, Place of Stay, Marital Status, Highest Level ofEducation, current living arrangement (e.g. staying alone or with family) and Occupation. It further includesregular employment status and current employment status(e.g, Work from home, temporary leave, termination etc)
4. 4.History of illness (Present or past) History of physical ailment specified (diabetes, hypertension, heart ailment or being on any steroid or any other chronic ailment) Previous history of H1N1/ Influenza like illness
5. 5.COVID-19 Information This section includes time spent focusing on COVID related information, current stressors with respect to COVID-19 and coping mechanisms used. This further includesinformation on resources available to participants near their place of stay and information of any known diagnosed case of COVID-19.
6. 6.Standardized Scales to be used Generalized Anxiety Disorder Scale (GAD-7); Patient Health Questionnaire (PHQ-9) Powered by

Conditions

COVID-19

Outcome Measures

Primary Outcomes (2)

• Prevalence (magnitude) of anxiety of general adult population during COVID-19

  To understand the prevalence (magnitude) of depression and anxiety of general adult population during COVID-19 using Generalized Anxiety Disorder Scale (GAD-7)

  1 YEAR

• prevalence (magnitude) of depression and anxiety of general adult population during COVID 19

  To understand the prevalence (magnitude) of depression and anxiety of general adult population during COVID-19 using Patient Health Questionnaire (PHQ-9).

  1 Year

Interventions

Registery Data Collection BEHAVIORAL

Observational Data Collection

Eligibility Criteria

• Age: 18 Years - 90 Years
• Sex: all
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Probability Sample

Study Population

Participants of the age of 18 years and above Participants residing in India Participants with minimum 10 years of education with basic knowledge of English

You may qualify if:

• Participants of the age of 18 years and above
• Participants residing in India
• Participants with minimum 10 years of education with basic knowledge of English

You may not qualify if:

• Participants under the age of 18 years
• Participants residing outside of India
• Participants with previous history of any major psychiatric illness, psychiatric hospitalization or currently on any psychiatric medication.

Sponsors & Collaborators

• Max Healthcare Insititute Limited: lead

Study Sites (1)

Max Super Speciality hospital

New Delhi, National Capital Territory of Delhi, 110017, India

RECRUITING

MeSH Terms

Conditions

COVID-19

Condition Hierarchy (Ancestors)

Pneumonia, Viral; Pneumonia; Respiratory Tract Infections; Infections; Virus Diseases; Coronavirus Infections; Coronaviridae Infections; Nidovirales Infections; RNA Virus Infections; Lung Diseases; Respiratory Tract Diseases

Study Officials

• Sameer Malhotra

  max healthcare

  PRINCIPAL INVESTIGATOR

Central Study Contacts

Sameer Malhotra

CONTACT

9891059770; Sameer.Malhotra@maxhealthcare.com

Shreya Singhal

CONTACT

9810022980; Sameer.Malhotra@maxhealthcare.com

Study Design

• Study Type: observational
• Observational Model: OTHER
• Time Perspective: CROSS SECTIONAL
• Target Duration: 12 Months
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: April 28, 2020
• First Posted: April 30, 2020
• Study Start: April 24, 2020
• Primary Completion: November 24, 2020
• Study Completion: February 24, 2021
• Last Updated: July 15, 2020

Record last verified: 2020-07

Locations

IN (1)